Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2017 2024

• 3 Active

Projects per year

A phase 3, open-label, randomised study to compare the efficacy and safety of luspatercept (Ace-536) versus epoetin alfa for the treatment of anaemia due to Ipss-R very low, low or intermediate risk myelodysplastic syndromes (MDS) in ESA naive subjects who require red blood cell transfusions [ACE-536-MDS-002]

Kenealy, M. & Baker, E.

20/12/18 → 31/12/24

Project: Research

Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies for lung or gastrointestinal cancers:an investigator-initiated, open-label, multicentre, randomised, phase 3 trial [Target-TP].

Kenealy, M. & Baker, E.

20/09/18 → 31/12/20

Project: Research

The PRECISE assay: Personalised medicine for cancer patients using next-generation sequencing

To, S. Q. G., Azad, A., Shortt, J., Wei, A., Shackleton, M. & Kenealy, M.

1/12/17 → 1/12/20

Project: Research

Research Output 2015 2015

• 1 Letter

Research Output per year

2 Citations (Scopus)

Complete remission of Waldenström's associated generalized crystal-storing histiocytosis of IgM lambda subtype with bortezomib-based combination chemotherapy

Baird, S. M., Kenealy, M. K. & Hoy, R., 2 Nov 2015, In : Leukemia and Lymphoma. 56, 11, p. 3233-3235 3 p.

Research output: Contribution to journal › Letter › Other › peer-review